NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

RENB

Renovaro Inc

Jul 01 • 04:00PM ET

0.2720

Dollar change -0.0169
Percentage change -5.85	%

Healthcare • Biotechnology • USA • NASD

Peers: ENPH SEDG RUN CSIQ FSLR JKS NOVA AY NEE

| Held by: VTI VXF IWM VTWO IWO IWN VTWG IWC VTWV MSSM

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.47	Insider Own	51.33%	Shs Outstand	162.39M	Perf Week	-23.62%
Market Cap	46.82M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	83.77M	Perf Month	-12.17%
Enterprise Value	52.22M	PEG	-	EPS next Q	-	Inst Own	12.77%	Short Float	5.97%	Perf Quarter	-49.93%
Income	-74.78M	P/S	-	EPS this Y	-	Inst Trans	-0.56%	Short Ratio	1.46	Perf Half Y	-69.99%
Sales	0.00M	P/B	0.50	EPS next Y	-	ROA	-50.56%	Short Interest	5.00M	Perf YTD	-67.44%
Book/sh	0.54	P/C	28.72	EPS next 5Y	-	ROE	-67.13%	52W High	2.10 -87.05%	Perf Year	-81.87%
Cash/sh	0.01	P/FCF	-	EPS past 3/5Y	-16.97% -13.58%	ROIC	-84.13%	52W Low	0.27 0.74%	Perf 3Y	-91.83%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	11.65% 16.50%	Perf 5Y	-92.59%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	58.00%	Oper. Margin	-	ATR (14)	0.05	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.13	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	36.27	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	0.13	EPS Q/Q	100.22%	SMA20	-18.94%	Beta	0.49	Target Price	-
Payout	-	Debt/Eq	0.08	Sales Q/Q	-	SMA50	-17.99%	Rel Volume	0.34	Prev Close	0.29
Employees	25	LT Debt/Eq	0.01	Earnings	-	SMA200	-58.17%	Avg Volume	3.42M	Price	0.27
IPO	Feb 02, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	- -	Trades		Volume	1,176,990	Change	-5.85%

Jun-30-25 09:21AM	Renovaro Launches AI-Based Neurotoxin Countermeasure Initiative Addressing Emerging National Security Needs (ACCESSWIRE)
Jun-10-25 11:13AM	Smart Healthcare Is Taking Over. Here's Where the Money's Headed (PR Newswire) +5.61%
Jun-03-25 09:15AM	Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform (GlobeNewswire)
May-23-25 09:17AM	AI Could Add $461 Billion to Global Healthcare--And These New Platforms Are Leading the Charge (PR Newswire)
May-22-25 09:41PM	Renovaro Inc. Accelerates 2025 Lawsuit to Force Predictive Oncology Merger (Insider Monkey) +15.28%
03:12PM	Loading…
03:12PM	UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology (GlobeNewswire)
11:05AM	Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology (GlobeNewswire)
May-14-25 09:15AM	Renovaro Launches Augusta, an AI-Powered Precision Neurology Platform (GlobeNewswire)
May-13-25 09:15AM	Renovaro and Amsterdam University Medical Center Announce Exclusive Collaboration to Advance Blood Platelet RNA Diagnostics (GlobeNewswire)
Apr-22-25 09:20AM	Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs (GlobeNewswire) -13.32%
Apr-09-25 09:25AM	Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine (GlobeNewswire)
Apr-05-25 12:10PM	China announces retaliatory tariffs, U.S. unemployment rises: Morning Buzz (TipRanks)
Apr-04-25 09:40AM	Renovaro Provides Update to Definitive Agreement with Predictive Oncology (GlobeNewswire) -16.49%
Mar-03-25 09:15AM	Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology (GlobeNewswire) -9.05%
09:00AM	Predictive Oncology Moves to Finalize Definitive Merger Agreement With Renovaro Biosciences (GlobeNewswire)
01:25PM	Loading…
Feb-26-25 01:25PM	Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine (GlobeNewswire) +53.95%
09:15AM	Renovaro Announces $15 million in Equity Committed (GlobeNewswire)
Feb-19-25 10:10AM	Investors Eye Biotech Sector as Cancer Therapy Market Surges (PR Newswire) +5.64%
Jan-07-25 09:15AM	Renovaro Issues Shareholder Letter and Provides Corporate Update (GlobeNewswire) -7.68%
09:15AM	Renovaro Appoints Nathen Fuentes as Chief Financial Officer (GlobeNewswire)
Jan-06-25 09:15AM	Renovaro to Acquire Predictive Oncology in All-Stock Transaction (GlobeNewswire) +7.99%
09:10AM	Predictive Oncology Announces Agreement to be Acquired by Renovaro (GlobeNewswire)
Dec-30-24 09:00AM	Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV (GlobeNewswire) -5.07%
Dec-23-24 09:00AM	RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program (GlobeNewswire) -31.71%
Dec-20-24 03:40PM	Renovaro Regains Compliance with NASDAQ Listing Requirement (GlobeNewswire) +6.15%
09:00AM	Renovaro Enters into a Strategic Collaboration with Nebul to Advance a Paradigm Shift for Early Disease Detection (GlobeNewswire)
Nov-04-24 08:31AM	Renovaro Issues Shareholder Letter and Provides Corporate Update (GlobeNewswire) +15.44%
Oct-17-24 09:15AM	RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing (GlobeNewswire) -20.30%
Oct-16-24 09:28AM	Renovaro Announces Strategic Restructuring and Leadership Transition (GlobeNewswire) +32.01%
Sep-19-24 09:00AM	PersonalAIze and Cube Forge Groundbreaking Partnership to Accelerate AI-Driven Healthcare Platform and Point of Care Diagnostics (GlobeNewswire)
09:00AM	Loading…
Sep-17-24 09:00AM	Independent Expert Assessment Validates RenovaroCube's Potential as a Groundbreaking AI Platform Starting with Early Cancer Detection (GlobeNewswire) -5.16%
Sep-13-24 09:00AM	RenovaroCube to Present Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology Congress (GlobeNewswire) +5.51%
Sep-11-24 09:15AM	RenovaroCube Announces Strategic Offering of Up to 20% Ownership (GlobeNewswire)
Jul-26-24 07:36AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
05:30AM	The Junk in Your Index Fund Is Costing You Big-Time (The Wall Street Journal)
Jun-14-24 09:06AM	Renovaro, Inc. Announces $10 million in Equity Committed (GlobeNewswire) +13.10%
May-24-24 09:20AM	Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy (GlobeNewswire) +7.58%
08:45AM	Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032 (GlobeNewswire)
May-16-24 08:53AM	RENB Stock Earnings: Renovaro Biosciences Reported Results for Q3 2024 (InvestorPlace)
Apr-30-24 11:00AM	Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics (GlobeNewswire)
Apr-24-24 09:00AM	RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership (GlobeNewswire)
Apr-18-24 08:45AM	Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient Care (GlobeNewswire)
Mar-04-24 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Waldencast, Chemours, Trupanion, and Renovaro and Encourages Investors to Contact the Firm (GlobeNewswire) +12.99% -7.28%
Feb-15-24 09:25AM	Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace (GlobeNewswire) -8.68%
Feb-14-24 10:01AM	Statement of Renovaro Inc (GlobeNewswire) +14.06%
Feb-13-24 09:46AM	Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace (GlobeNewswire) -42.86%
09:31AM	AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine (GlobeNewswire)
Jan-25-24 12:45PM	Renovaro Biosciences Announces Results of Special Meeting of Shareholders (GlobeNewswire) +7.38%
Jan-18-24 09:30AM	Renovaro BioSciences Releases CEO Shareholder Message (NewMediaWire)
Jan-16-24 08:00AM	Message from Renovaro Bioscience, Inc.'s CEO, The Hon. Mark Dybul, MD (GlobeNewswire)
Nov-28-23 08:30AM	Renovaro BioSciences CEO Featured in Recent Proactive Interview (NewMediaWire) -5.83%
Nov-23-23 09:30AM	Renovaro BioSciences Poised to Spearhead Advancements in Battle Against Diseases (NewMediaWire)
Nov-22-23 10:44AM	Renovaro Biosciences CEO unveils potential breakthrough therapies and AI partnerships for 2024 (News Direct)
Nov-21-23 08:30AM	Renovaro BioSciences Eyes Opportunity in Precision Medicine Market (NewMediaWire)
Nov-14-23 09:00AM	Renovaro Biosciences CEO Provides Update on Combination with GEDiCube (NewMediaWire)
Nov-10-23 08:30AM	Renovaro BioSciences, GEDi Cube Combine to Transform Medicine Through AI, Biotherapeutics (NewMediaWire) +5.38%
Nov-07-23 08:30AM	Renovaro Biosciences Adds Three New Members to Board as Definitive Agreement with GEDiCube Announced (NewMediaWire)
Oct-24-23 09:00AM	Renovaro BioSciences CEO Provides Insights on Agreement to Combine with GEDi Cube (NewMediaWire) -7.61%
Oct-11-23 09:25AM	Avram Miller, Co-Founder of Intel Capital, Joins Renovaro Biosciences Board of Directors (GlobeNewswire) -5.89%
08:30AM	Renovaro BioSciences Announces Board Appointments of Two Finance Experts (NewMediaWire)
Oct-10-23 08:00AM	Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors (GlobeNewswire) +19.08%
Oct-04-23 09:00AM	Renovaro BioSciences CEO Releases Shareholder Letter (NewMediaWire)
Oct-02-23 12:05PM	Message from Renovaro Biosciences CEO, The Hon. Mark Dybul, MD (GlobeNewswire) +5.15%
09:25AM	AI Company GEDiCube and Renovaro Biosciences Sign Definitive Agreement to Combine (GlobeNewswire)
08:30AM	Renovaro BioSciences Enters Definitive Agreement to Combine with Leading AI Tech GEDi Cube (NewMediaWire)
Sep-29-23 09:15AM	Renovaro Biosciences and AI Health Company GEDi Cube Sign Definitive Agreement to Combine (GlobeNewswire) +9.83%
09:15AM	GEDi Cube and Renovaro Biosciences Sign Definitive Agreement to Combine (Business Wire)
Sep-21-23 03:00PM	Renovaro BioSciences Targets Pancreatic Cancer Through Work With GEDI Cube AI Platform, NVIDIA Resources (NewMediaWire) +13.57%
Sep-19-23 08:30AM	Why Renovaro BioSciences Inc. Is 'One to Watch' (NewMediaWire)
Sep-06-23 12:40AM	Renovaro BioSciences Congratulates GEDiCube on New Joint Effort Clinical Trials (NewMediaWire) -6.98%
Aug-30-23 09:15AM	Renovaro BioSciences Welcomes GEDiCube Announcement of New Joint Effort (GlobeNewswire) +13.08%
Aug-21-23 09:15AM	Renovaro BioSciences Congratulates GEDi Cube on Appointment of its Chief Medical Officer (GlobeNewswire) +7.78%
Aug-10-23 12:06AM	Renovaro BioSciences, GEDi Cube Announce LOI to Merge, Focus on Fight Against Cancer (NewMediaWire)
Aug-09-23 09:00AM	AI Company GEDi Cube and Renovaro Biosciences Announce a Binding, Exclusive Letter of Intent to Merge, Accelerating Fight Against Cancer (GlobeNewswire) +82.35%
Jul-17-23 07:29AM	3 Doomed Biotech Stocks Destined for Disaster (InvestorPlace) +5.16%
Jun-23-23 05:00PM	Enochian BioSciences Inc. Announces Adjournment of 2023 Annual Stockholder Meeting (GlobeNewswire) -15.73% -13.37%
Jun-08-23 08:45AM	Enochian BioSciences Announces that its Cancer Platform Remains on Track for Trials in Humans Following FDA Review (GlobeNewswire) -6.31%
Apr-03-23 09:00AM	Enochian BioSciences CEO Letter to Shareholders (GlobeNewswire) +10.37%
Mar-29-23 09:00AM	Enochian BioSciences Announces a Scientific Presentation of Proof-of-Concept Studies for a Potential Therapy for Cancers with a Poor Life Expectancy by a Leading Researcher (GlobeNewswire)
Mar-13-23 08:30AM	Enochian BioSciences Achieves Full Compliance with NASDAQ Filing Requirements (GlobeNewswire) +6.54%
Feb-23-23 04:04PM	Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended December 31, 2022 (GlobeNewswire) +19.77%
Nov-30-22 05:20PM	Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended September 30, 2022 (GlobeNewswire) -22.26%
Oct-26-22 12:01AM	Corrections & Amplifications (The Wall Street Journal) -8.04%
Oct-24-22 08:11PM	Biotech Co-Founder, Facing Murder-for-Hire Charges, Accused of Fabricating Data (The Wall Street Journal) -7.11%
08:00AM	Enochian BioSciences Forges Ahead With Focused Approach, Promising Future (GlobeNewswire)
Oct-21-22 05:00PM	Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Annual Report on Form 10-K (GlobeNewswire)
Oct-17-22 08:30AM	Enochian BioSciences Awarded U.S. Patent For Its Promising Oncology Platform (GlobeNewswire) +7.34%
Sep-01-22 08:08AM	Enochian Biosciences, Inc. (NASDAQ:ENOB) insiders have significant skin in the game with 49% ownership (Simply Wall St.)
Jul-25-22 10:15AM	Enochian BioSciences Appoints Dr. Richard Whitley As Senior Scientific Advisor (GlobeNewswire) -10.50%
Jul-01-22 08:37PM	Enochian Biosciences Finds Falsified Data in Study of Covid-19 Treatment (The Wall Street Journal) +17.62%
05:00PM	Enochian BioSciences Announces Findings From A Rigorous Internal Review of Scientific Data (GlobeNewswire)
Jun-27-22 03:00PM	Biotech Wizard Left a Trail of FraudProsecutors Allege It Ended in Murder (The Wall Street Journal) -21.92%
Jun-10-22 04:00PM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Enochian Biosciences (ENOB) Investors with Significant Losses to Contact Firms Attorneys, Firm Investigating Possible Securities Law Violations (ACCESSWIRE) +12.84% -8.20%
Jun-09-22 05:59PM	Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Enochian To Contact Him Directly To Discuss Their Options (ACCESSWIRE) -5.10%
May-31-22 08:00AM	Scientific Leaders Agree on Promise of Enochian BioSciences (GlobeNewswire)
May-25-22 04:20PM	Enochian BioSciences Board Learns of Arrest of Co-Founder and Inventor and Expresses Strong Confidence in the Promising Future of the Company (GlobeNewswire) -36.97% +20.00%
Apr-20-22 07:00AM	Enochian BioSciences Announces the Appointment of Executive Vice President of Research and Development with 25 years of Industry Experience (GlobeNewswire)
Apr-07-22 06:00AM	Enochian BioSciences Announces Appointment of Senior Vice President for Clinical Operations with 32 Years Experience at Pfizer (GlobeNewswire) -10.77%
Apr-06-22 09:07AM	Innovative Clinical Strategies to Treat HIV and Cancer Presented by Pioneering Research Scientist at the Innate Killer Summit in San Diego (PR Newswire)
Apr-05-22 06:00AM	Enochian BioSciences Inventor and Co-Founder Presents Data on Novel Clinical Approaches as the Invited, Concluding Plenary Speaker at the Innate Killer Summit (GlobeNewswire)

Renovaro, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. The company was founded by Rene Sindlev and Serhat Gumrukcu on January 18, 2011 and is headquartered in Los Angeles, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
William Anderson Wittekind	10% Owner	Jul 29 '24	Sale	1.30	1,114	1,448	840,319	Oct 24 08:56 AM
William Anderson Wittekind	10% Owner	Jul 17 '24	Sale	1.46	16,362	23,889	841,433	Jul 19 05:44 PM
William Anderson Wittekind	10% Owner	Jul 15 '24	Sale	1.41	21,954	30,955	875,795	Jul 17 04:32 PM
William Anderson Wittekind	10% Owner	Jul 10 '24	Sale	1.51	75,000	113,250	894,645	Jul 15 08:46 AM
William Anderson Wittekind	10% Owner	Jul 11 '24	Sale	1.51	14,896	22,493	897,749	Jul 15 08:46 AM
William Anderson Wittekind	10% Owner	Jul 09 '24	Sale	1.53	4,630	7,084	969,645	Jul 15 08:46 AM
William Anderson Wittekind	10% Owner	Jul 05 '24	Sale	1.55	60,000	93,000	974,275	Jul 08 04:50 PM
William Anderson Wittekind	10% Owner	Jul 03 '24	Sale	1.51	50,000	75,500	1,034,275	Jul 08 04:50 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

RENB

Renovaro Inc

Upgrade your FINVIZ experience